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Legionella pneumophila, the causative agent of Legionnaires’ disease, is a waterborne bacteriummainly found in man-made water
systems in close association with free-living amoebae and multispecies biofilms. Pseudomonas strains, originating from various
environments including freshwater systems or isolated fromhospitalized patients, were tested for their antagonistic activity towards
L. pneumophila. A high amount of tested strains was thus found to be active. This antibacterial activity was correlated to the
presence of tensioactive agents in culture supernatants. As Pseudomonas strains were known to produce biosurfactants, these
compounds were specifically extracted and purified from active strains and further characterized using reverse-phase HPLC and
mass spectrometry methods. Finally, all biosurfactants tested (lipopeptides and rhamnolipids) were found active and this activity
was shown to be higher towards Legionella strains compared to various other bacteria. Therefore, described biosurfactants are
potent anti-Legionella agents that could be used in the water treatment industry although tests are needed to evaluate how effective
they would be under field conditions.
1. Introduction
Bacteria of the Legionella genus are Gram-negative nat-
ural inhabitants of freshwater environments. Among the
65 Legionella species referenced to date, L. pneumophila is
the leading cause of severe pneumonia called Legionnaires’
disease (LD). Furthermore the serogroup 1 is responsible for
82.9% of the cases in Europe [1] and for over 80% of the
cases worldwide [2, 3]. L. pneumophila can colonize man-
made water settings from natural water sources, being now
considered as an opportunistic plumbing pathogen. Through
the literature, we can notice that LD outbreaks have been
linked to a variety of water sources like cooling towers,
drinking water supply systems, spa pools, and even street
cleaning trucks [4–6]. Multiplication of Legionella in those
artificial water systems is highly facilitated by temperatures
around 35∘C and factors such as water stagnation, poormain-
tenance, no or reduced water disinfection and the presence
of free-living protozoa feeding on biofilms [7, 8]. Biofilms
have been identified as an ecological key niche in which L.
pneumophila survives and stays in wait for its natural hosts,
amoebae, and ciliates [9]. Indeed, protozoan predators are the
natural hosts of L. pneumophila, and humans are accidental
hosts as judged by the evidence that only a single and recent
case of probable human-to-human transmission has been
reported to date [10]. Following the uptake of L. pneumophila
by phagocytic cells, this bacterium avoids lysosomemediated
degradation and forms a unique replication-permissive com-
partment within its host cell, called the Legionella containing
vacuole (LCV) [11]. After replication, they are able to evade
LCV, escape from the spent host cell, and disseminate in the
environment looking for new suitable hosts (for recent review
see [12]).
In order to survive in water sources, L. pneumophila is
facing other biological challengers aside from protozoa as
represented by others microbial inhabitants. In 2008, a study
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screened 80 aquatic bacterial strains including 5 referenced
strains and showed that 66.2% displayed antagonistic activity
against L. pneumophila [13]. Interestingly, among the Pseu-
domonas genus (representing 75% of all tested strains), 72%
were active. However, to date, the antagonistic molecules of
interest remain uncharacterized. On the other hand, several
authors have shown that many Pseudomonas species can
produce biosurfactants which are surface-active compounds.
Those compounds known to display various functional prop-
erties like in structural biofilm formation/cells dispersion
also exhibit particularly lytic and growth-inhibitory activ-
ities against a broad range of microorganisms, including
viruses,mycoplasmas, bacteria, fungi, and oomycetes [14–16].
Among the wide range of structurally different biosurfactants
that have been identified to date, Pseudomonas species can
produce glycolipids and lipopeptides [17, 18]. Lipopeptides
are constituted by a lipid tail linked to a short cyclic or
linear peptide moiety. Based on differences in the length
and composition of the lipid moiety as well as in the type,
number and configuration of the amino acids in the peptide
chain were initially classified into four groups: Amphisin,
syringomycin, tolaasin, and viscosin [19]. However, several
lipopeptides produced by Pseudomonas spp. which were
characterized later displayed structural features which dif-
fer from these archetypes like putisolvins, syringofactins,
and orfamides that extend the initial classification [20–22].
The first lipopeptide described in the literature and which
remains the best known biosurfactant to date is surfactin
produced by many Bacillus strains [23]. Members of the
surfactin family are constituted of a heptapeptide moiety
linked to a 𝛽-hydroxylated fatty acid to form a cyclic lactone
ring and display antiviral and antibacterial activities [24].
Recently, a surfactinmixture produced by the strainB. subtilis
AM1 was found active against various Legionella strains,
including nonpneumophila, pneumophila serogroup 1, and
pneumophila nonserogroup 1 strains [25]. To the best of our
knowledge, this is the first time that such an activity was
demonstrated and this study remains the only one published
so far. This activity was striking as several reviews have
highlighted a limited activity of many lipopeptides against
Gram-negative bacteria [14, 15, 17]. However, lipopeptides
produced by Pseudomonas and Bacillus species have not
been tested extensively for activity against other saprophytic
bacteria, but mostly for activity against human pathogenic
bacteria like Bacillus sp. or Mycobacterium sp. [14]. The
surfactin mixture from B. subtilis AM1 was also able to break
down existing biofilms of L. pneumophila [25] suggesting that
it could represent a potent tool for the biological control of the
pathogen in the water treatment industry.
Rhamnolipids are glycolipid secondary metabolites typ-
ically constituted of dimer of 3-hydroxy fatty acids linked
through a beta glycosidic bond to a mono- or di-rhamnose
moiety [26]. Up to now, more than one hundred rhamno-
lipids homologues have been discovered mainly in Pseu-
domonas species even if several bacteria belonging to other
genera like Burkholderia or Acinetobacter were also reported
to produce rhamnolipids [27].These amphiphilic biodegrad-
able molecules have been reported to be useful as bio-
logical control agents due to their intrinsic wide-ranging
antimicrobial potency [28]. For example, the mixture (six
homologues) extracted from the P. aeruginosa LBI strains
displayed a high activity against many bacterial strains
like Enterobacter aerogenes and Proteus mirabilis with MIC
between 4 and 8 𝜇g/ml [29]. Also, various bacterial species
were sensitive to the P. aeruginosa 47T2 mixture (up to 11
homologues), Enterobacter aerogenes being by far the most
sensitive one (MIC of 4 𝜇g/ml) [30]. To date, except for
surfactin which was already described for its anti-Legionella
activity [25], neither lipopeptide nor rhamnolipid mixture
was reported to be active against bacteria of the Legionella
genus.
The aim of our studywas to discover and characterize nat-
ural anti-Legionella compounds produced by Pseudomonas
strains. Therefore, a bacterial collection with both clinical
and environmental strains was built and screened to find
Pseudomonas sp. with the capacity to inhibit the growth
of L. pneumophila. Biomolecules responsible for this antag-
onistic activity were then purified by RP-HPLC and their
chemical structures were elucidated by LC-MS-MS. Antimi-
crobial activities were determined against selected Gram-
positive and Gram-negative indicator strains including many
Legionella species.
2. Materials and Methods
2.1. Bacterial Strains. Pseudomonas strains used in this study
are listed in Table 1 while other bacterial strains are listed in
Tables 5 and 6. Pseudomonas strains were routinely cultured
at 28∘C for nonaeruginosa strains or 37∘C for aeruginosa
strains either on LB agar plates or in LB broth under shaking
(180 rpm). LB was composed of 5 g/l Yeast extract, 10g/l
Tryptone and 5 g/l NaCl. Legionella strains were cultured
at 37∘C either on buffered charcoal yeast extract (BCYE)
agar plates or in buffered yeast extract (BYE) liquid medium
under shaking (150 rpm). BYE was composed of 5 g/l N-(2-
Acetamido)-2-aminoethanesulfonic acid, 10 g/l Yeast extract
and pH 6.9. BCYE was made from BYE by adding 2 g/l
Activated charcoal and 15 g/l Agar. L. pneumophila Lens CIP
108286 [31] was used as the main target for anti-Legionella
activity assays. Other bacteria were grown either on Brain
Heart Infusion (BHI; Fisher Scientific, Illkirch, France) agar
plates or broth, at 30∘C or 37∘C, depending on the tested
strain.
2.2. Culture Conditions and Reagents. Rhamnolipids produc-
tion was achieved by cultivating Pseudomonas strains at 30∘C
for 96 h under shaking (180 rpm) in a mineral salt medium
(MSM) with mannitol (20 g.l−1) as the only carbon source
[41]. For lipopeptides production, Pseudomonas strains were
grown at 17∘C for 96 h under shaking (180 rpm) in MSM
medium supplemented with glucose (20 g.l−1).
A commercial solution of rhamnolipids was purchased
from Sigma-Aldrich (Reference R95DD; Sigma-Aldrich,
St. Louis, MO, USA). Rhamnolipids were dissolved in a
water/acetonitrile (ACN) (65:35, v/v) mixture with 4 mM
ammonium acetate at a final concentration of 5 mg.ml−1.
Stock solutions were stored at 4∘C and freshly diluted in
sterile distilled water prior to each experiment. All other
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reagents were purchased from Sigma-Aldrich (Saint-Louis,
MO, USA) unless stated otherwise.
2.3. In Vitro Antibacterial Assays
2.3.1. Spot on Lawn Assay. The target strain, L. pneumophila
Lens, was spread (100 𝜇l at OD600 = 0.1) onto a BCYE agar
plate. Then, 10 𝜇l of overnight cultures of each Pseudomonas
strain was spotted onto the surface of the agar plate before
incubation for 96 h at 28∘C or 37∘C. An inhibition area,
around the producing strain, revealed the antibacterial activ-
ity.
2.3.2. Well Diffusion Assay. A L. pneumophila Lens suspen-
sion (100 𝜇l at OD600 = 0.1) was spread onto a BCYE agar
plate. Wells were punched into the agar and filled with 100 𝜇l
of 15 times concentrated supernatants of active Pseudomonas
strains. Plates were then incubated 96 h at 37∘C. Antibacterial
activity was revealed by a zone of inhibition around the well.
2.3.3. Determination of Minimum Inhibitory Concentrations.
Minimum inhibitory concentrations (MICs) of biosurfac-
tants towards various bacterial strains weremeasured accord-
ing to the dilution method detailed elsewhere [42]. MIC was
defined as the lowest concentration of biosurfactant required
to totally inhibit the growth of a selected strain after a chosen
incubation period (24 h or 96 h), depending on the tested
strain.
2.4. Detection of Biosurfactants
2.4.1. Drop Collapse Test. A drop of 50 𝜇l of each active
Pseudomonas strain supernatant, containing 2.5 𝜇l of a 20
mg. ml−1 methylene blue solution, was placed on a piece of
parafilm. Drops containing biosurfactants collapse, whereas
nonsurfactant-containing drops remain stable. In this study,
concentrated LB broth (15X) was used as a negative control
while surfactin produced by Bacillus subtilis LMG 28342 [25]
was used as a positive control.
2.4.2. AminoAcids and SugarsDetection. Thepeptidemoiety
of lipopeptideswas detected using a 0.25%ninhydrin solution
(prepared in acetone and acetic acid). A sample volume of
10 𝜇l was spotted onto a silica plate (Saint-Louis, MO, USA).
The plate was then sprayed with ninhydrin and heated at
105∘Cuntil development of a purple color. Surfactin produced
by Bacillus subtilis LMG 28342 [25] was used as a positive
control.The sugarmoiety of rhamnolipids was detected using
a 0.15% anthrone solution. A sample volume of 10 𝜇l was
spotted onto a silica plate and the plate was then sprayed
with anthrone. The presence of sugars was revealed by the
development of a blue color. Glucose and a commercial
solution of rhamnolipids were both used as positive controls.
2.5. Extraction of Biosurfactants
2.5.1. Lipopeptides. Bacteria were removed from MSM cul-
ture medium by centrifugation (10,000 x g, 30 min, 4∘C) and
the resulting supernatant was sterilized by filtration through
a 0.22 𝜇m syringe filter (Sarstedt AG & Co. KG, Germany).
Then, the cell-free supernatant was extracted three times with
ethyl acetate (1:1, v/v). The collected organic fractions were
evaporated under vacuum, and the residue was dissolved in 5
ml of H2O/ACN (3:2, v/v).The resulting solution was termed
“Lipopeptides raw extract”.
2.5.2. Rhamnolipid. Bacteria were removed from MSM cul-
ture medium by centrifugation (10,000 x g, 30 min, 4∘C) and
the resulting supernatant was sterilized by filtration through a
0.22 𝜇m syringe filter (Sarstedt AG&Co. KG, Germany).The
supernatant pH was then adjusted to 3 (using 1M HCl). The
resulting acidified cell-free supernatant was extracted three
times with ethyl acetate (1:1, v/v) and the collected organic
fractions were evaporated under vacuum. The crude extract
was then dissolved in 5 ml of H2O/ACN (3:2, v/v) and the
solution was named “Rhamnolipids raw extract”.
2.6. Purification of Biosurfactants
2.6.1. Lipopeptides. The “Lipopeptides raw extracts” were
diluted in a H2O/ACN (1:1, v/v) mixture with 0.2% formic
acid and separated by reverse-phase HPLC. Separation was
conducted on a Chromolith SpeedROD RP-18e reverse-
phase HPLC column (4.6 x 50 mm) (Merck Millipore,
Billerica, MA, USA) with a Dionex P680 HPLC pump, fitted
with aDionexUltiMate 3000 detector. Elutionwasmonitored
at 205 nm, 214 nm and 280 nm. Separation was carried out
using a H2O/ACN/formic acid 0.2% (v/v) solvent system.
After an initial 2 min wash with 60% ACN, elution was
achieved in 23 min at a flow rate of 0.8 ml min−1 with an 18
min linear gradient from 60 to 100% ACN, followed by a 5
min wash with 100% ACN. All the collected fractions were
lyophilized and stored at -20∘C for further studies.
2.6.2. Rhamnolipids. The “Rhamnolipids raw extracts” were
diluted in a H2O/ACN (1:1, v/v) mixture with 4 mM ammo-
nium acetate and separated by reverse-phase HPLC similarly
as described above for lipopeptides. Separation was carried
out using a H2O/ACN/4mM ammonium acetate solvent
system. After an initial 4 min wash with 35% ACN, elution
was achieved in 31 min at a flow rate of 0.4 ml min−1 with a 5
min linear gradient from 35% to 50% ACN, 50% ACN for 6
min, followed by a linear 20 min gradient from 50% to 90%
ACN. Fractions were collected every minute, lyophilized and
stored at -20∘C for further studies.
2.7.Mass Spectrometry Analyses of Biosurfactants. Themolec-
ular masses of biosurfactants were determined by electro-
spray ionization mass spectrometry (ESI-MS) with a Xevo
Q-TOF (Waters, Milford, MA, USA) mass spectrometer.
Samples were suspended in 50%ACN/0.2% formic acid (v/v).
LC-MS mass spectra were performed, in positive mode for
lipopeptides and negative mode for rhamnolipids, with a
cone voltage ramping from 20 to 40 V. The spray voltage
was set to 3.0 kV, the source temperature to 120∘C and
the desolvation temperature to 450∘C. The LC separation
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was conducted using the same column and gradient as
for HPLC analyses indicated previously except for the flow
rate which was reduced to 0.5 ml min−1. LC-MS/MS mass
spectra were performed in the MSE mode (Waters, Milford,
MA, USA). Briefly, in the MSE mode, mass spectrometric
scans alternate all along the experiment between low (10 V)
and high (ramping from 30 to 60 V) fragmentation energy
delivering for the same LC separation two chromatograms
corresponding to MS and MS/MS analyses, respectively.
3. Results
3.1. Screening of a PseudomonasCollection. Twenty-onePseu-
domonas sp. strains of environmental or clinical origin
and representing eight different species were screened for
antagonistic activity against L. pneumophila Lens using a spot
on lawn assay. As presented in Table 1, an inhibition zone
was observed around all colonies of P. aeruginosa (3/3), P.
fluorescens (5/5), and, with a smaller diameter, P. syringae
(2/2). P. otitidis 4014 and P. sp. DSS73 also displayed a large
zone of inhibition. Surprisingly, only one of the 4 P. putida
strains tested appeared to be active against L. pneumophila
Lens. Therefore, these strains inhibited L. pneumophila Lens
growth via the production of, at least, one diffusible active
compound. On the contrary, no zone of inhibition was
observed around colonies of all tested P. fulva strains (3/3)
as well as P. cepacia 4512 and P. libanensis 4000. These strains
did not secrete any anti-Legionella compound or in too low
concentration to be detected.
In order to demonstrate that antimicrobial compounds
were effectively secreted by all the active strains, their culture
supernatants were also tested against L. pneumophila Lens by
well diffusion assay on BCYE plates (Table 1). Crude super-
natants did not show any antibacterial activity but after being
concentrated 15 times, an anti-Legionella activity, related to a
zone of inhibition around the well containing samples, was
observed. Anti-Legionella compounds were indeed secreted
by active bacteria cultivated in broth medium, but at quite
low amounts.
3.2. Chemical Nature of Active Compounds. Different mem-
bers of the genus Pseudomonas are known to produce biosur-
factants with antimicrobial activities [15, 28]. To check if the
anti-Legionella activity could be attributed to biosurfactants,
their presence in the culture supernatant was determined by
the drop collapse test. This qualitative test is indicative of the
surface-active and wetting activities [43] and it represents an
indirect measurement of surface activity of a biosurfactant.
Interestingly, the drops of culture supernatant for all inactive
strains remained stable, whereas the culture supernatant of all
active strains induced a drop collapse (Table 2). These results
indicate that the anti-Legionella compounds secreted by
Pseudomonas strains were correlated to the presence of bio-
surfactants. Therefore, putative biosurfactants were extracted
from culture supernatants using ethyl acetate as previously
described [41, 44].The subsequent extracts were found active
against L. pneumophilawhen tested using well diffusion assay
(Table 1). On the contrary, similar extracts obtained from
inactive strains did not display any activity. Moreover, all
aqueous extracts that correspond to the remaining cell-free
supernatants after extraction with ethyl acetate were found
inactive too.
The extracts obtained from the three P. aeruginosa strains
and P. otitidis 4014were found positively colored by anthrone,
but not ninhydrin, revealing the presence of glucidic com-
poundswhereas all the other active extractswere only colored
by ninhydrin (Table 2). These results indicated that tested
P. aeruginosa strains could produce rhamnolipids as well
as P. otitidis 4014. Other active strains were found to pro-
duce biosurfactants containing peptidic moieties, probably
lipopeptides. Finally, inactive strains did not produce any
glucidic or peptidic biosurfactants as indicated by the lack of
coloration (Table 2).
3.3. Purification and Identification of Lipopeptides. P. fluo-
rescens (MAFD21c, DSS73, MFAO2, PfA7b, and MFAH4a)
and P. putida MFAF88 were grown in MSM medium [44]
and lipopeptides were extracted with ethyl acetate. For each
strain, RP-HPLC chromatograms of ethyl acetate extracts
displayed at least two peaks (data not shown) which could
correspond to lipopeptides, according to Janek and coworkers
[44]. In parallel, extracts were analyzed by LC-MS and LC-
MS/MS in order to characterize active molecules. Results of
these analyses are summarized in Table 3. All of the active
fractions were found to contain a molecule displaying a
molecular mass already described in the literature (Table 3)
except for the P. sp. DSS73 fraction with a retention time of
11.9 min. The latter one molecular mass, which was named
Amphisin-like, is reduced by 14 Da as compared to Amphisin
and could correspond to the replacement of a leucine residue
by a valine in the peptidic part of the molecule. The other
lipopeptides produced by this strain correspond to Amphisin
and Tensin which were also found in the P. fluorescens
MFAO2 extract (Table 3). P. putida MFAF88 lipopeptides
were identified as Putisolvin I and II. Massetolide E and
Viscosin were identified in the P. fluorescens PfA7b extract.
Finally, P. fluorescens MHA4a and MFAD21c were both
found to produce PPZPM-1a and PPZPM-2a. Finally, full 1:1
identification is likely for the various lipopeptides, but must
await further confirmation through chemical or genomic
sequence analysis (Supplementary Table S1).
To estimate the proportion between lipopeptides con-
tained in each extract, the relative quantity for each molecule
was measured (Table 3). For some strains, in our conditions,
lipopeptides were produced in similar amounts (P. fluorescens
PfA7b and P. fluorescens MFAH4a) whereas for most of
strains (P. fluorescensMFAO2,MFAD21c, P. sp. DSS73, and P.
putida MFAF88) proportions of lipopeptides produced were
really dissimilar. Thus, proportions of Amphisin, Amphisin-
like and Tensin produced by the strain DSS73 were 78.4%,
18.2% and 3.4%, respectively, whereas for P. fluorescens
MFAO2, the biosurfactant mixture was composed of 6.1% of
Amphisin and 93.9% of Tensin.
3.4. Purification and Identification of Rhamnolipids. To char-
acterize the chemical structure of rhamnolipids produced by
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Table 1: Anti-Legionella pneumophila activity of Pseudomonas strains.
Pseudomonas strains
Anti-Legionella activitya
Reference/Sourceb
Colony Concentratedsupernatant (15X)
P. aeruginosa 8H +++ +++ EBI collection
P. aeruginosa CHA +++ +++ [32]
P. aeruginosa UCBPP-PA14 +++ +++ [33]
P. cepacia 4512 - - EBI collection
P. sp DSS73 +++ ++ [34]
P. fluorescensMFAD21c +++ + [35]
P. fluorescensMFAH4a +++ + [35]
P. fluorescensMFAO2 +++ ++ [35]
P. fluorescensMFE01 +++ + [36]
P. fluorescens PfA7b +++ + LMSM collection
P. fulva 1324 - - EBI collection
P. fulva B6 - - EBI collection
P. fulva B8 - - EBI collection
P. libanensis 4000 - - EBI collection
P. otitidis 4014 +++ + EBI collection
P. putida 1243 - - EBI collection
P. putida 1312 - - EBI collection
P. putidaMFAF88 ++ + [35]
P. putidaMFAK14 - - [35]
P. syringaeMFAA66a + - [35]
P. syringaeMFAE88 + - [35]
The anti-Legionella activity of the concentrated supernatant for each strain grown in LB medium is the mean of three independent experiments.
a-: no activity.
+: zone of inhibition with a diameter < 4 mm.
++: zone of inhibition with a diameter between 4 and 8 mm.
+++: zone of inhibition with a diameter > 8 mm.
bEBI: Laboratoire Ecologie & Biologie des Interactions, UMR CNRS 7267, Université de Poitiers; LMSM: Laboratoire de Microbiologie Signaux et
Microenvironnement, EA4312, Université de Rouen.
P. aeruginosa strains (8H, CHA and UCBPP-PA14) and P.
otitidis 4014, bacteria were cultivated in MSM broth contain-
ing mannitol as the only carbon source [41]. Rhamnolipids
extracted with ethyl acetate from culture supernatants were
then separated using RP-HPLC. Because rhamnolipids have
no UV-absorptive properties, fractions were blind collected
every minute during the elution and then tested against L.
pneumophila. In parallel, extracts were analyzed by LC-MS
and LC-MS/MS in order to characterize active molecules.
All fractions, which were found active against Legionella,
contained rhamnolipids with at least two congeners. Rham-
nolipids consist of one or two units of rhamnose linked to
one or two hydroxylated fatty acid with C8 to C12 chains,
which could be saturated or not. The molecular masses of
pseudomolecular ions and characteristic fragments observed,
respectively, in MS and MS/MS spectra are listed in Table 4.
Several types of rhamnolipids congeners of molecular masses
in the range m/z 473-703, depending on their number of
rhamnose residues and the length of their fatty acid chains,
were observed. Structural characterization was achieved
usingMS/MS spectra by detection of characteristic fragments
[29] and an example is detailed on Figures 1 and 2. The
m/z of the pseudomolecular ion [M-H]− of component
A is 649 Da (Figure 1(a)). Thus, the parent ion at m/z
649 was fragmented by MS/MS and showed daughter ions
at m/z 479 (x), 309, 339 (y), and 169 (z) (Figure 1(b)).
Fragment at m/z 309 is characteristic of di-rhamnolipids.
Indeed, it corresponds to the di-rhamnosyl residue (Figure 2).
The fragment at m/z 339 corresponds to the lipid moiety
composed of two hydroxylated fatty acids containing ten
carbons (C10). The fragment at m/z 479 results from the
rupture of the ester bond between the two fatty acids. This
fragment is characteristic of di-rhamnolipids carrying a C10
hydroxylated fatty acid directly linked to the carbohydrate
part of themolecule. Taken together, the component A is a di-
rhamnolipid carrying two C10 hydroxylated fatty acids (Rha-
Rha-C10 -C10) (Figure 2).
Up to 29 rhamnolipids homologues containing one or two
rhamnose residues linked to one or two hydroxylated fatty
acids were identified in Pseudomonas culture supernatants
(Table 4). P. aeruginosa PA14 produced the highest number of
homologues (25) and the lowest was found for P. aeruginosa
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Table 2: Determination of the chemical nature of active compounds produced by Pseudomonas strains.
Pseudomonas strains Drop collapseassay
Ethyl acetate
extract activity
Coloration by
anthrone
Coloration by
ninhydrin
P. aeruginosa 8H + + + -
P. aeruginosa CHA + + + -
P. aeruginosa UCBPP-PA14 + + + -
P. cepacia 4512 - - - -
P. sp DSS73 + + - +
P. fluorescensMFAD21c + + - +
P. fluorescensMFAH4a + + - +
P. fluorescensMFAO2 + + - +
P. fluorescensMFE01 + + - +
P. fluorescens PfA7b + + - +
P. fulva 1324 - - - -
P. fulva B6 - - - -
P. fulva B8 - - - -
P. libanensis 4000 - - - -
P. otitidis 4014 + + + -
P. putida 1243 - - - -
P. putida 1312 - - - -
P. putidaMFAF88 + + - +
P. putidaMFAK14 - - - -
P. syringaeMFAA66a + + - +
P. syringaeMFAE88 + + - +
+: three independent assays give a positive result.
-: three independent assays give a negative result.
8H (11). Only 7 rhamnolipid homologues (Rha-C10 C8; Rha-
C10 C10; Rha-Rha-C10 C8; Rha-Rha-C10 C10; Rha-Rha-C10
C12:1; Rha-Rha-C10 C12; Rha-Rha-C10) were produced by the
3 strains. Interestingly, P. aeruginosa 8H secreted only di-
rhamnosyl carrying two fatty acids species.
Finally, the orcinol reaction revealed that extracts con-
tained rhamnose amounts of 79.95 ± 16.61 mg/ml for P.
aeruginosa 8H, 66.84 ± 3.43 mg/ml for P. aeruginosa CHA,
10.99 ± 4.18 mg/ml for P. aeruginosa UCBPP-PA14 and 4.07
± 1.56 mg/ml for P. otitidis 4014. It has to be noted that the
rhamnolipid content of P. aeruginosa 8H extract is overesti-
mated because it contains only di-rhamnosyl rhamnolipids
contrarily to the other strains extracts.
3.5. Anti-Legionella Activity of Biosurfactants
3.5.1. Lipopeptides. Firstly, HPLC fractions corresponding
to identified lipopeptides were collected, concentrated and
tested against L. pneumophila. All fractions were found active
except those corresponding to the molecules with the lowest
proportions, Putisolvin II (23.4%), Amphisin-like (18.2%),
Tensin in DSS73 extract (3.4%) and Amphisin in MFAO2
extract (6.1%) (Table 3). Because Amphisin and Tensin were
found active when obtained in larger amounts from other
extracts, we supposed that Tensin from the strain DSS73,
Putisolvin II and Amphisin-like appeared inactive because
of their low concentration. It has to be noted that it is
impossible to quantify the amounts of lipopeptides using
classical colorimetric methods. To confirm this proposal,
fractions corresponding to each of these two molecules were
obtained from more than twenty HPLC runs and pooled
before being concentrated. In both cases, fractions were
found active against L. pneumophila. In conclusion, all the
lipopeptides produced by Pseudomonas species were found
to be active against L. pneumophila.
Secondly, the antagonistic potency of the purified
lipopeptide mixtures was determined against various bacte-
rial strains previously used in antibacterial assays [25, 45, 46].
Because it was difficult to quantify the lipopeptide content of
extracts, activities were expressed as a function of the first
twofold dilution of the extract which totally inhibited the
growth of the target bacteria (Table 5). All of the mixtures
were more or less active against Legionella species. However,
mixtures were not active against the other Gram-negative or
Gram-positive bacteria tested so far.Thus, these results highly
suggest a specific activity of lipopeptide mixtures against
bacteria of the Legionella genus. The P. fluorescens MFAH4a
extract seemed to be the less active one, with activities
observed only for undiluted to four times diluted solutions.
On the contrary, P. fluorescens PfA7b extract appeared to be
the most antibacterial extract (Table 5).
3.5.2. Rhamnolipids. MICs of the rhamnolipid mixtures pro-
duced by Pseudomonas strains cultured in MSM broth were
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Table 4: Chemical composition of rhamnolipid mixtures produced by Pseudomonas strains.
Rhamnolipid structure [M-H]
-
(m/z)
Ion fragments
(m/z)
Pseudomonas strain
PA14 8H CHA 4014
Mono-rhamno-di-lipid
Rha-C8-C8 447 Nd + - - -
Rha-C10-C8:1 473 327 - - - +
Rha-C8:1-C10 473 333 - - - +
Rha-C10-C8 475 333 + - + +
Rha-C8-C10 475 305 + - + +
Rha-C10-C10 503 339, 333, 169 + - + +
Rha-C10-C12:1 529 333, 195 + - + -
Rha-C12:1-C10 529 359, 169 + - + -
Rha-C10-C12 531 333 + - - -
Rha-C12-C10 531 361 + - - -
Di-rhamno-mono-lipid
Rha-Rha-C8 451 Nd + - + -
Rha-Rha-C10 479 Nd + - + -
Rha-Rha-C12:2 503 Nd + - + -
Di-rhamno-di-lipid
Rha-Rha-C8:1-C8:1 589 449, 309, 279, 140 - - - +
Rha-Rha-C8-C8 593 451, 142 + + + -
Rha-Rha-C10-C8 621 479, 142 + + + +
Rha-Rha-C8-C10 621 451, 169 + + + +
Rha-Rha-C10-C10:1 647 479, 337, 309, 167 - + - -
Rha-Rha-C8-C12:1 647 451 + - - -
Rha-Rha-C12:1-C8 647 505 + - - -
Rha-Rha-C10-C10 649 479, 339, 309, 169 + + + +
Rha-Rha-C11-C10 665 494, 309, 169 + + - -
Rha-Rha-C10-C11 665 479, 309, 184 + + - -
Rha-Rha-C10-C12:1 675 479, 365, 309, 195 + + + +
Rha-Rha-C12:1-C10 675 505, 365, 309, 169 + + + +
Rha-Rha-C10-C12 677 479, 367, 309, 197 + + + +
Rha-Rha-C12-C10 677 507, 367, 309, 169 + + + +
Rha-Rha-C12-C12:1 703 507, 311 + - - -
Rha-Rha-C12:1-C12 703 505, 311 + - - -
+: presence of the rhamnolipid in the extract.
-: absence of the rhamnolipid in the extract.
Nd: not detected.
determined against the same collection of bacterial strains
used for lipopeptides. Results are given in Table 6. Extracts
were found highly active against all the Legionella sp. tested
with low MIC values between 0.027 and 25 𝜇g/ml. The
mixture produced by P. aeruginosa 8H was the most effective
against Legionella sp, with the lowest MIC values. On the
opposite, the extract originating from P. aeruginosa CHA
culture supernatant and commercial rhamnolipid mixture
displayed 10 to 100-fold higher MICs.
Interestingly, rhamnolipid mixtures were found less or
not active against other tested bacteria. B. subtilis appeared
sensitive to the rhamnolipid extracts but not to commercial
mixture. The P. aeruginosa 8H extract displayed activity
against most of the other bacteria tested but not S. aureus. In
contrast, S. aureus was found sensitive to P. aeruginosa CHA
(52.5 𝜇g/ml) extracts. Finally, the P. aeruginosa 8H extract
appears about 2 to 10 times more active than the one from
P. aeruginosa PA14 and displays an anti-Legionella activity
from 5 to 50 times higher than both P. aeruginosa CHA
and the commercial mixture. Taken together, these results
indicate that Legionella sp. are particularly sensitive to the
rhamnolipid mixtures produced by Pseudomonas sp.
In order to evaluate the activity of various homologues
of rhamnolipids, HPLC fractions obtained from the four
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Table 6: Antibacterial spectrum of rhamnolipid mixtures produced by Pseudomonas strains.
MIC of rhamnolipid mixtures (𝜇g/ml)
8H CHA PA14 4014 Commercial mixture
A. hydrophila LMG 2844 - - - - -
B. subtilis AM1 41.2 80 26.3 100 -
E. faecalis V583 41.2 - - - -
E. coli DH5Y 20.6 - - - -
F. breve LMG 4011 82.5 - - - -
K. pneumoniae 050283 165 - - - -
L. bozemanii ATCC 33217 0.2 6.2 1.6 5.2 7.8
L. dumoffii ATCC 33279 0.4 12.5 0.4 5.2 15.6
L. feeleii ATCC 35072 0.2 6.2 0.4 3.9 11.7
L. longbeachae ATCC 33484 0.4 12.5 3.3 7.9 13.1
L. micdadei ATCC 33218 0.03 3.1 3.3 3.9 15.6
L. pneumophila ATCC 33155 (Sg 3) 0.2 12.5 3.3 15.8 8.8
L. pneumophila ATCC 33215 (Sg 6) 0.2 6.2 0.4 7.9 3.9
L. pneumophila ATCC 33216 (Sg5) 0.05 25 1.6 7.9 19.5
L. pneumophila ATCC Baa74 130b 0.05 12.5 0.4 7.9 15.6
L. pneumophila Corby (Sg1) 0.2 12.5 3.3 5.2 11.7
L. pneumophila Lens CIP 108286 (Sg1) 0.4 12.5 1.6 10.5 11.7
L. ivanovii Li4pVS2 41.2 - - - -
L. monocytogenes EGDe ATCC BAA-679 41.2 - - - -
P. aeruginosa LMG 1242 - - - - -
P. aeruginosa PA14 82.5 - - - -
S. enterica J18 82.5 - - - -
S. aureus ATCC 29213 - 805 52.5 50 -
-: no growth of inhibition was detected even with undiluted rhamnolipid mixture (660 𝜇g/ml for the 8H mixture, 1610 𝜇g/ml for the CHA extract, 105 𝜇g/ml
for the PA14 extract, 100 𝜇g/ml for the 4014 extract, and 250 𝜇g/ml for the commercial mixture).
Bacteria (106 CFU/ml) were incubated in BYE or BHImediumwith two-fold dilutions of rhamnolipidmixtures. Results correspond to theMIC after incubation
for 24h or 96 h at 37∘C depending on the tested strain and are the mean of three independent experiments.
Bacterial strains were obtained from various culture collections: ATCC: American Type Culture Collection, CIP: Collection Institut Pasteur, France, and LMG:
BCCM/LMG Bacteria Collection, Ghent University, Belgium.TheCorby strain was kindly provided by the Centre National de Référence des Légionelles (Lyon,
France). Other strains were from the laboratory culture collection. Sg: serogroup.
producing strains were tested against L. pneumophila and
then their content was analyzed by LC-MS in order to
identify all the rhamnolipid species (Data not shown). All
fractions were found more or less active against Legionella
according to their amount of rhamnolipids, estimated from
their peaks area in LC-MS chromatograms (data not shown).
However, all these fractions were found to contain at least
two rhamnolipid homologues. Consequently, even if many of
these molecules are undoubtedly active against Legionella, it
is not possible to affirm which one is effectively active against
Legionella.
4. Discussion
Artificial water settings provide suitable conditions for
growth and multiplication of waterborne pathogens includ-
ing L. pneumophila. In those nutrient-poor environments, L.
pneumophila is able to interact positively with other microor-
ganisms to obtain the nutrients it requires to survive [9, 47].
Although much work has been conducted on the stimulation
of Legionella growth by other microorganisms, little work has
been done on the negative interactions that occur between
Legionella bacteria and other microorganisms in man-made
water systems. Compilation of latest findings shows that
many bacterial genera isolated from drinking water pipes
were able to inhibit the growth of Legionella species [13, 48–
50]. While active isolated strains were taxonomically diverse,
bacteria belonging to the Pseudomonas genus were always
found or tested. Another constant of those studies is the
lack of molecular identification of active compounds that
have been thought to be bacteriocins or bacteriocin-like
substances [13, 48].
To further investigate the chemical nature of those anti-
Legionella compounds, a Pseudomonas sp. collection, com-
prising both environmental and clinical strains, was defined
and screened. Among the 21 tested strains, 14 were active
against L. pneumophila (66.7%). This result is in good agree-
ment with the data published by Guerrieri and coworkers
as they found 72% of active Pseudomonas strains in their
collection [13]. The anti-Legionella compounds secreted by
Pseudomonas strains were then correlated to the presence
of biosurfactants, as Pseudomonas members are well known
to produce many biosurfactants with antimicrobial activities
[15, 28].
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Figure 1: MS (a) and MS/MS (b) spectra of the RP-HPLC fraction eluted at 19 min from P. aeruginosa CHA extract.
Lipopeptides constitute a specific class of microbial sec-
ondary metabolites produced by a wide range of microor-
ganisms. Moreover, those produced by Bacillus and Pseu-
domonas species are the most studied by far [17]. Here, all
active fractions purified from five P. fluorescens and one
P. putida ethyl acetate extracts contained various already
known lipopeptides. According to the literature, only the
molecule with a molecular mass of 1383 Da is original. Thus,
this lipopeptide was named Amphisin-like as its molecular
mass is 14 Da lower than the molecular mass of Amphisin
[39]. We also found lipopeptides belonging to the orfamide
group named PPZPMs, a group of CLPs thought to be the
missing link between the viscosin and Amphisin groups due
to the number of amino acids forming the cyclic moiety
[22, 38]. Lipopeptides are mainly characterized by highly
structural diversity and are considered as multifunctional
microbial tools. Indeed, they exhibit a very wide range of
biological activities including lytic and growth-inhibitory
activities against a broad range of microorganisms [14]. In
particular, many authors have reported antibacterial activ-
ities (for review see [17]). Usually, Gram-negative bacteria
are poorly inhibited by lipopeptides whereas Gram-positive
bacteria appear more susceptible [15, 17, 19]. To date, only
one lipopeptide was reported to be active against Legionella
species [25]. It corresponds to surfactin, a well characterized
lipopeptide produced by Bacillus species. However, all the
lipopeptides tested were found active against Legionella
species. It is the first time, to our knowledge, that Pseu-
domonas biosurfactants were shown to be active against
Legionella. Interestingly, other Gram-negative and Gram-
positive bacteria tested were insensitive to those compounds
used at a similar concentration. In many studies, when avail-
able, MIC values of lipopeptides against bacteria ranged from
less than 10 𝜇g/ml (massetolide A and viscosin against M.
tuberculosis) to around 1 mg/L (milkisin against S. enterica)
[37, 51]. Thus, MIC determined in this study were in a
similar concentration range. Nevertheless, Legionella species
appeared more sensitive to surfactin than to Pseudomonas
lipopeptides asMIC values were lower (1-4𝜇g/ml) [25]. Inter-
estingly, Loiseau and coworkers showed that nonlegionella
bacterial strains tested were resistant to surfactin, even at the
highest tested concentration (265 𝜇g/mL). Taken together,
those data highlight a very specific sensitivity of Legionella
bacteria to lipopeptides.
Interestingly, rhamnolipids extracts were active against all
the Legionella tested, whatever their species. The percentage
of di-rhamno-di-lipid in each mixture was higher than those
of monorhamno-di-lipid and di-rhamno-monolipid. This
result is in good agreement with previous observation of
Arino and coworkers [52]. Interestingly, the P. aeruginosa
8H extract, which is the more active, contained the lower
number of rhamnolipid congeners as compared to other
extracts. It could be related to the higher concentration of
each rhamnolipidmolecule in the extract. Indeed, in all cases,
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Figure 2: Fragmentation of di-rhamnolipids observed in MS/MS analysis. The m/z of the fragments as a function of the structures of fatty
acids is indicated.
the rhamnolipid content was evaluated as a function of its
rhamnose content. Thus, the mean concentration of each
congener is higher for P. aeruginosa 8H which contained
11 different rhamnolipids than those of P. aeruginosa CHA
(16 congeners), PA14 (25 congeners) and P. otitidis 4014 (13
congeners). However, this cannot explain the higher activity
of P. aeruginosa PA14 as compared to P. aeruginosa CHA.
The other main difference of P. aeruginosa 8H extract as
compared to the others corresponds to its content restricted
to di-rhamnosyl species which could then be related to its
higher anti-Legionella activity. Moreover, this P. aeruginosa
8H extract was found to be the most active towards no-
Legionella strains except S. aureus and B. subtilis for which
the P. aeruginosa PA14 and P. otitidis 4014 extracts were found
the most active. On the other hand, the insensitivity of S.
aureus to the P. aeruginosa 8H extract could be related to its
particular content restricted to di-rhamnosyl species. Indeed,
the comparison of the rhamnolipids congeners produced by
P. aeruginosa PA14 (this study), CHA (this study), AT10 [53],
LBI [29] and RL 47T2 [30] did not reveal the presence of
a specific anti-Staphylococcus aureus compound. However,
all these extracts contained monorhamnosyl species which
could be postulated to exert this specific activity. Strikingly,
Legionella species were shown to be highly sensitive to
rhamnolipid mixtures as MIC values were quite low (0.03-
19.5 𝜇g/ml) while throughout the literature, many sensitive
bacterial species displayed higher MIC values [27, 28]. Does
Legionella bacteria possess some specificity that could explain
this high sensitivity? As these compounds are membrane
active, maybe a part of the answer is hidden in the compo-
sition of the cell envelope. Indeed, Legionella are also highly
sensitive to detergents (SDS, Tween 80, Triton X-100. . .) or
detergent-like molecules such as antimicrobial peptides [25,
45, 54, 55].Thus, the phospholipid composition of Legionella
cell envelope as well as the membrane thickness, the fluidity,
the presence of phospholipids clusters and even composition
of the lipopolysaccharide could be key parameters involved in
Legionella sensitivity towards membrane-active compounds
[56].
5. Conclusions
In this study, we showed, for the first time, that biological
challengers present in the microenvironment of Legionella
such as Pseudomonas bacteria exhibit antagonistic activ-
ity because of the production of various biosurfactants
species. These compounds are known to be multifunctional
biomolecules with many depicted potential biotechnological
applications including their use as antimicrobials [57]. Thus,
the wide sensitivity of Legionella species to rhamnolipids
and lipopeptides make biosurfactants promising tool for
their biological control in water treatment industry although
experimental data are needed to evaluate how effective
biosurfactants would be in real conditions.
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